Total Funding
85
27
Total FundingCorporate Round raised
Growth Score 85 in past quarter
-10 pts
Heat Score 27 in past quarter
-45 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33163
AMPLY uses machine learning and synthetic biology to mine vast biological data to discover novel drug and nutraceutical candidates.
- Ben Thomas: Co-founder, CEO, and CTO
- Oliver Rausch: Chief Scientific OfficerPast Role: Storm Therapeutics, Chief Scientific Officer
About the Company
AMPLY deploys machine learning and synthetic biology to mine vast biological data to discover novel drug and nutraceutical candidates. Using a proprietary in silico and in vitro platform we discover first-in-class molecules. AMPLY is helping tackle some of humankind's greatest challenges such as cancer, metabolic diseases, and MDR infections.